The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation

NCT01423188 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease
Dyslipidemia

Interventions

DRUG: RVX000222
DRUG: Placebo RVX000222

Sponsor

Resverlogix Corp

Collaborators

[object Object]